Has Acemini been launched in China? How do domestic patients obtain it: How to safely purchase genuine drugs?
Asciminib is mainly used to treat chronic myelogenous leukemia (CML). Its original drug has not yet been officially launched in China. Therefore, domestic patients cannot purchase the drug directly through formal channels, nor can they obtain reimbursement through medical insurance policies. This means that Acemini’s current access to drugs in China is relatively limited. For patients in urgent need of treatment, the most common option is to purchase drugs overseas, especially from markets such as Europe.
In overseas markets, the common specifications of the European version of Asiminib’s original drug are 40mg*60 tablets, and the price is about 40,000 yuan or more. It should be noted that since drug prices are affected by exchange rate fluctuations, prices may change. In addition, patients will need to consider additional costs such as international shipping costs and possible customs duties when purchasing. Although more expensive, aceminib's efficacy makes it a worthy treatment choice for patients who are ineffective or resistant to traditional tyrosine kinase inhibitors (TKIs).

In addition to the original drug, some generic drugs of Aceminid can also be found in overseas markets. For example, the generic drug produced by Lucius Pharmaceutical Factory in Laos has similar ingredients and efficacy to the original drug. The specification is also 40mg*60 tablets. The price is much lower than the original drug, usually more than 2,000 yuan. Although the price is cheap, because the production process and quality control standards of generic drugs may differ, patients need to be extra cautious when choosing, ensuring that they are from legal sources and purchased through reliable channels.
For Chinese patients, the main ways to obtain Assimini include overseas purchase and cross-border e-commerce platforms. However, since China has not yet approved the official marketing of Aceminib, patients should pay special attention to the legality and quality of the drug when choosing purchase channels. For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.
Reference materials:https://www.novartis.com/our-products/pipeline/asciminib
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)